Monday, April 10, 2023 7:40:41 AM
You do not understand how a conflict of interest is defined.
You just guessed “probably” what involvement 70 investigators in the trial had. Nobody cares about your guesses.
The number of patients at a site is irrelevant to authorship.
Patient level data is tabulated in the JAMA article.
Dr. Stupp is a proponent of the Optune helmet, whose data sucked. Even Dr. Stupp would not sign on to Novocure’s claims as their later articles trended more and more manipulated. Dr. Stupp is a proponent of Optune and Temodar for GBM, both result in a true survival of only about 3% at five years, but he extrapolated data from two years out to five years out to pretend he had 12% survival in the Optune trial (more likely 3% survival) but then hid the data. Follow up was discontinued after two years from last patient enrolled because survival curve was degrading.
You just guessed “probably” what involvement 70 investigators in the trial had. Nobody cares about your guesses.
The number of patients at a site is irrelevant to authorship.
Patient level data is tabulated in the JAMA article.
Dr. Stupp is a proponent of the Optune helmet, whose data sucked. Even Dr. Stupp would not sign on to Novocure’s claims as their later articles trended more and more manipulated. Dr. Stupp is a proponent of Optune and Temodar for GBM, both result in a true survival of only about 3% at five years, but he extrapolated data from two years out to five years out to pretend he had 12% survival in the Optune trial (more likely 3% survival) but then hid the data. Follow up was discontinued after two years from last patient enrolled because survival curve was degrading.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
